SCHEMBL68538

SCHEMBL68538

CCC(C)(C)C(C)c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 3/20 0.45
HRH1 P35367 2/20 0.42
CACNA1F O60840 1/20 0.42
CHRM2 P08172 1/20 0.42
CHRM1 P11229 1/20 0.42
ADRA2B P18089 1/20 0.42
CHRM3 P20309 1/20 0.42
ADRA1A P35348 1/20 0.42
OPRK1 P41145 1/20 0.42
CACNA1D Q01668 1/20 0.42
SLC6A3 Q01959 1/20 0.42
KCNH2 Q12809 1/20 0.42
CACNA1S Q13698 1/20 0.42
CACNA1C Q13936 1/20 0.42
SCN5A Q14524 1/20 0.42
TAAR1 Q96RJ0 4/20 0.41
LMNA P02545 1/20 0.41
TRPA1 O75762 3/20 0.38
SLC6A4 P31645 1/20 0.38
AOC3 Q16853 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22315109 0.88 PTGS2 (0.44) TAAR1
SCHEMBL17400135 0.85 ALDH1A1 (0.44) RIPK1HRH1CACNA1FCHRM2CHRM1
SCHEMBL17854020 0.83 RIPK1 (0.47) RIPK1HRH1CACNA1FCHRM2CHRM1
SCHEMBL22766210 0.82 RIPK1 (0.45) RIPK1HRH1CACNA1FCHRM2CHRM1
SCHEMBL11543845 0.80 RIPK1 (0.48) RIPK1HRH1CACNA1FCHRM2CHRM1
SCHEMBL27214704 0.80 TRPA1 (0.44) RIPK1HRH1CACNA1FCHRM2CHRM1
SCHEMBL8127525 0.80 RIPK1 (0.44) RIPK1HRH1CACNA1FCHRM2CHRM1
SCHEMBL7767977 0.80 RIPK1 (0.44) RIPK1HRH1CACNA1FCHRM2CHRM1
SCHEMBL20990566 0.79 RIPK1 (0.44) RIPK1HRH1CACNA1FCHRM2CHRM1
SCHEMBL21438353 0.79 TAAR1 (0.43) RIPK1HRH1CACNA1FCHRM2CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11746189-B2 Hard-mask forming composition, method for manufacturing electronic component, and resin TOKYO OHKA KOGYO CO., LTD. (JP) 2023-09-05 US disclosed
US-20170037935-A1 CHAIN TSUBAKIMOTO CHAIN CO. (JP) 2017-02-09 US disclosed
US-20170037934-A1 CHAIN TSUBAKIMOTO CHAIN CO. (JP) 2017-02-09 US disclosed
US-20140283972-A1 RESIN COMPOSITION, RESIN SHEET, AND CURED RESIN MATERIAL AND METHOD FOR PRODUCING THE SAME HITACHI CHEMICAL COMPANY, LTD. (JP) 2014-09-25 US disclosed
US-8288003-B2 Method for producing phosphorus-containing phenolic compound, novel phosphorus-containing phenol, curable resin composition, cured product of the same, printed wiring board, and semiconductor sealing material DIC CORPORATION (JP) 2012-10-16 US disclosed
US-20120095156-A1 METHOD FOR PRODUCING PHOSPHORUS-CONTAINING PHENOLIC COMPOUND, NOVEL PHOSPHORUS-CONTAINING PHENOL, CURABLE RESIN COMPOSITION, CURED PRODUCT OF THE SAME, PRINTED WIRING BOARD, AND SEMICONDUCTOR SEALING MATERIAL DIC CORPORATION (JP) 2012-04-19 US disclosed
US-8129467-B2 Curing accelerating compound-silica composite material, method for producing curing accelerating compound-silica composite material, curing accelerator, curable resin composition, and electronic component device HITACHI CHEMICAL CO., LTD. (JP) 2012-03-06 US disclosed
US-20110165513-A1 PHOTORESIST COMPOSITION SUMITOMO CHEMICAL COMPANY LTD (JP) 2011-07-07 US disclosed
US-20090062460-A1 CURING ACCELERATING COMPOUND-SILICA COMPOSITE MATERIAL, METHOD FOR PRODUCING CURING ACCELERATING COMPOUND-SILICA COMPOSITE MATERIAL, CURING ACCELERATOR, CURABLE RESIN COMPOSITION, AND ELECTRONIC COMPONENT DEVICE HITACHI CHEMICAL CO., LTD. (JP) 2009-03-05 US disclosed
US-5180799-A Organolithium-Organoaluminum Catalyst IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1993-01-19 US disclosed
EP-0434316-A1 Processes ZENECA LIMITED (GB) 1991-06-26 EP disclosed
US-4450279-A PHOTOPOLYMERIZATION SENSITIZERS FOR UNSATURATED MONOMERS; RAPID HARDENING; STORAGE STABILITY NIPPON, KAYAKU, KABUSHIKI, KAISHA (JP) 1984-05-22 US disclosed
US-4178327-A FIREPROOFING THE DOW CHEMICAL COMPANY (US) 1979-12-11 US disclosed
US-4054733-A MOLDING MATERIALS THE DOW CHEMICAL COMPANY (US) 1977-10-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120095156-A1 METHOD FOR PRODUCING PHOSPHORUS-CONTAINING PHENOLIC COMPOUND, NOVEL PHOSPHORUS-CONTAINING PHENOL, CURABLE RESIN COMPOSITION, CURED PRODUCT OF THE SAME, PRINTED WIRING BOARD, AND SEMICONDUCTOR SEALING MATERIAL PPA1, RBBP4, SMARCB1 RIPK1 1386/4885HRH1 837/4885CACNA1F 1723/4885
US-20090062460-A1 CURING ACCELERATING COMPOUND-SILICA COMPOSITE MATERIAL, METHOD FOR PRODUCING CURING ACCELERATING COMPOUND-SILICA COMPOSITE MATERIAL, CURING ACCELERATOR, CURABLE RESIN COMPOSITION, AND ELECTRONIC COMPONENT DEVICE NCAPH, RAD51, H1-2 RIPK1 1768/4885HRH1 190/4885CACNA1F 2272/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.